Active, not recruiting
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
NCT06496178
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- Site 160 Mobile, Alabama, United States
- Site 102 Prescott, Arizona, United States
- Site 125 Scottsdale, Arizona, United States
- Site 82 Duarte, California, United States